Nuclear Antigen anticorps

N° du produit ABIN6297660

Détail du produit anti-Nuclear Antigen anticorps

Antigène: Nuclear Antigen (IPO-38)

Reactivité: Humain, Souris, Rat

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Nuclear Antigen est non-conjugé

Application: Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (IHC)

Fonction: Mouse anti-Human/Mouse/Rat IPO-38 Antibody (Proliferation Marker) [Sodium Azide Free]

Specificité: Nuclear

Purification: Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.

Immunogène: Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.

Information d'application

Indications d'application: Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 0.5-1 μg/mL
Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1)
Prediluted format: incubate for 30 min at RT (2)

Restrictions: For Research Use only

Stockage

Buffer: In 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.

Détails sur Nuclear Antigen

Antigène: Nuclear Antigen (IPO-38)

Autre désignation: IPO38 (IPO-38 Produits)

Sujet:

Target Description: Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO38 antigen is present in the nuclei of proliferating cells such as Hodgkin s disease and non-Hodgkin s lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO38 may be a useful marker of cell proliferation during monitoring of tumor progression.